Covid 19 Impact on Global Active Pharmaceutical Ingredients API Market Size Status and Forecast 2020 2026

Global Active Pharmaceutical Ingredients (API) Market Outlook 2022

Q: How big is the Active Pharmaceutical Ingredients Market?

Ans. The global Active Pharmaceutical Ingredients (API) market was valued at US$ 67700 million in 2020 and it is expected to reach US$ 105780 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.

Q: Who are the Top manufacturers in the Active Pharmaceutical Ingredients Industry?

Ans. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.

Q: Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

Code: QYRE-Auto-31E2189

Report

April 2020

Pages:150

QYResearch

Description

Table of Content

Tables & Figures

Active Pharmaceutical Ingredients Market

The global Active Pharmaceutical Ingredients (API) market was valued at US$ 67700 million in 2020 and it is expected to reach US$ 105780 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027, growing at a CAGR of 6.6% during 2021-2027. Key drivers of the API market include the growing number of chronic diseases augmenting the need for pharmaceutical drugs.

Active Pharmaceutical Ingredients market

The increasing trend of outsourcing API production and rise in R&D initiatives by key players will drive the growth of the active pharmaceutical ingredients market during the forecast period. Moreover, the emergence of biosimilar drugs due to patent expiry of biological drugs will significantly boost the market growth in the coming years.

Trends Infuencing the Global API Market

Rising chronic diseases across the globe

An aging population, sedentary lifestyle and rapid urbanization has increased the rate of chronic diseases worldwide. Cancer, diabetes, respiratory problems and heart diseases are spreading rapidly . This has increased the need for innovative pharmaceutical drugs for better diagnosis and cure. The burden on healthcare and pharmaceutical industry has increased. These factors are expected to drive the growth of Active Pharmaceutical Ingredients market during the forecast period.

API production outsource and R&D initiatives

Many small and mid sized pharmaceutical companies donot have the means to comply with strict regulatory requirements related to product quality, quantity and effectiveness of clinical trials. This prompts them to outsouce the production of APIs to CDMOs(Contract Development and Manufacturing Organizations) who have the technical expertise, manufacturing capacity and regulatory backing. The outsourcing reduces costs and speeds up the process of clinical trials leading to better production of API drugs. Moreover key players are investing into R&D initiatives to provide personalized treatment through active pharmaceutical ingredient medications. This is expected to provide lucrative opportunities for the growth of the Active Pharmaceutical Ingredients market in the coming years.

Advent of biosimilar market

Biosimilars are generic drugs that share the same traits with respect to safety, purity, efficacy to that of biological drugs. The gradual patent expiry of several biological drugs has increased the need for biosimilars which are cheaper and receive quick approvals. The increasing burden on healthcare industry to provide quality treatment at low costs has augmented the demand for these drugs thereby surging the growth of the Active Pharmaceutical Ingredients market during the forecast period.

Active Pharmaceutical Ingredients Market Share

Based on type, the synthetic segment is expected to provide huge scope for growth in the Active Pharmaceutical Ingredients market share due to high availability of raw materials and easy regulatory protocols for manufacturing.

Based on application, the cardiovascular segment will provide immense opportunities for growth in the Active Pharmaceutical Ingredients market share as cardiovascular diseases are common are rising rapidly and innovative API drugs are required for accurate treatment.

Based on region, North America is expected to dominate in the Active Pharmaceutical Ingredients market share due to growing chronic diseases and government support. However, the Asia-Pacific segment will grow the fastest due to changing lifestyles, R&D initiatives and technological advancements in drug development. India is expected to hold a significant share of 30% in the global market.

Segment by Type

Synthetic APIs
Biotech APIs

Segment by Application

CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Segment by Company

Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Production by Region

North America
Europe
China
Japan
India

Consumption by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Scope of API Market Report

Report Metric	Details
Report Name	Active Pharmaceutical Ingredients Market
Market size value in 2020	USD 67700 Million
Revenue forecast in 2027	USD 105780 Million
Growth Rate	6.6%
Base year considered	2020
Forecast Period	2021-2027
By Type	Synthetic APIs, Biotech APIs
By Application	Cardiovascular, CNS, Oncology, Respiratory, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes
Report Coverage	Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	By Type, Application, and Region
Geographic Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How big is the Active Pharmaceutical Ingredients Market?

Ans. The global Active Pharmaceutical Ingredients (API) market was valued at US$ 67700 million in 2020 and it is expected to reach US$ 105780 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.

2. Who are the Top manufacturers in the API Industry?

Ans. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

4. Which region holds largest market share in the Active Pharmaceutical Ingredients?

Ans. India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%.

1 Study Coverage

1.1 Active Pharmaceutical Ingredients (API) Product Introduction

1.2 Market Segments

1.3 Key Active Pharmaceutical Ingredients (API) Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type

1.4.2 Synthetic APIs

1.4.3 Biotech APIs

1.5 Market by Application

1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application

1.5.2 CNS

1.5.3 Cardiovascular

1.5.4 Genitourinary/Hormonal Drugs

1.5.5 Respiratory

1.5.6 Rheumatology

1.5.7 Diabetes

1.5.8 Oncology

1.5.9 Others

1.6 Coronavirus Disease 2019 (Covid-19): Active Pharmaceutical Ingredients (API) Industry Impact

1.6.1 How the Covid-19 is Affecting the Active Pharmaceutical Ingredients (API) Industry

1.6.1.1 Active Pharmaceutical Ingredients (API) Business Impact Assessment - Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Active Pharmaceutical Ingredients (API) Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Active Pharmaceutical Ingredients (API) Players to Combat Covid-19 Impact

1.7 Study Objectives

1.8 Years Considered

2 Executive Summary

2.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts

2.1.1 Global Active Pharmaceutical Ingredients (API) Revenue 2015-2026

2.1.2 Global Active Pharmaceutical Ingredients (API) Sales 2015-2026

2.2 Active Pharmaceutical Ingredients (API) Market Size by Region: 2020 Versus 2026

2.2.1 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Sales by Region: 2015-2020

2.2.2 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Active Pharmaceutical Ingredients (API) Competitor Landscape by Players

3.1 Active Pharmaceutical Ingredients (API) Sales by Manufacturers

3.1.1 Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2015-2020)

3.1.2 Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2015-2020)

3.2 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers

3.2.1 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2015-2020)

3.2.2 Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2019

3.2.5 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Active Pharmaceutical Ingredients (API) Price by Manufacturers

3.4 Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Product Types

3.4.1 Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Active Pharmaceutical Ingredients (API) Product Type

3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

4.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020)

4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020)

4.1.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Active Pharmaceutical Ingredients (API) Market Size Forecast by Type (2021-2026)

4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2021-2026)

4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2021-2026)

4.2.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Active Pharmaceutical Ingredients (API) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

5.1 Global Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

5.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020)

5.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application (2015-2020)

5.1.3 Active Pharmaceutical Ingredients (API) Price by Application (2015-2020)

5.2 Active Pharmaceutical Ingredients (API) Market Size Forecast by Application (2021-2026)

5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2021-2026)

5.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2021-2026)

5.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2021-2026)

6 North America

6.1 North America Active Pharmaceutical Ingredients (API) by Country

6.1.1 North America Active Pharmaceutical Ingredients (API) Sales by Country

6.1.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country

6.1.3 U.S.

6.1.4 Canada

6.2 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type

6.3 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application

7 Europe

7.1 Europe Active Pharmaceutical Ingredients (API) by Country

7.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country

7.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country

7.1.3 Germany

7.1.4 France

7.1.5 U.K.

7.1.6 Italy

7.1.7 Russia

7.2 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type

7.3 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application

8 Asia Pacific

8.1 Asia Pacific Active Pharmaceutical Ingredients (API) by Region

8.1.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region

8.1.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region

8.1.3 China

8.1.4 Japan

8.1.5 South Korea

8.1.6 India

8.1.7 Australia

8.1.8 Taiwan

8.1.9 Indonesia

8.1.10 Thailand

8.1.11 Malaysia

8.1.12 Philippines

8.1.13 Vietnam

8.2 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type

8.3 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application

9 Latin America

9.1 Latin America Active Pharmaceutical Ingredients (API) by Country

9.1.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Country

9.1.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Country

9.1.3 Mexico

9.1.4 Brazil

9.1.5 Argentina

9.2 Central & South America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type

9.3 Central & South America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application

10 Middle East and Africa

10.1 Middle East and Africa Active Pharmaceutical Ingredients (API) by Country

10.1.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country

10.1.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country

10.1.3 Turkey

10.1.4 Saudi Arabia

10.1.5 UAE

10.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type

10.3 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application

11 Company Profiles

11.1 Teva

11.1.1 Teva Corporation Information

11.1.2 Teva Description, Business Overview and Total Revenue

11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered

11.1.5 Teva Recent Development

11.2 Mylan

11.2.1 Mylan Corporation Information

11.2.2 Mylan Description, Business Overview and Total Revenue

11.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered

11.2.5 Mylan Recent Development

11.3 DSM

11.3.1 DSM Corporation Information

11.3.2 DSM Description, Business Overview and Total Revenue

11.3.3 DSM Sales, Revenue and Gross Margin (2015-2020)

11.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered

11.3.5 DSM Recent Development

11.4 Aurobindo Pharma

11.4.1 Aurobindo Pharma Corporation Information

11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue

11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)

11.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered

11.4.5 Aurobindo Pharma Recent Development

11.5 Aspen

11.5.1 Aspen Corporation Information

11.5.2 Aspen Description, Business Overview and Total Revenue

11.5.3 Aspen Sales, Revenue and Gross Margin (2015-2020)

11.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered

11.5.5 Aspen Recent Development

11.6 Novartis

11.6.1 Novartis Corporation Information

11.6.2 Novartis Description, Business Overview and Total Revenue

11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)

11.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered

11.6.5 Novartis Recent Development

11.7 BASF

11.7.1 BASF Corporation Information

11.7.2 BASF Description, Business Overview and Total Revenue

11.7.3 BASF Sales, Revenue and Gross Margin (2015-2020)

11.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered

11.7.5 BASF Recent Development

11.8 Pfizer

11.8.1 Pfizer Corporation Information

11.8.2 Pfizer Description, Business Overview and Total Revenue

11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)

11.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered

11.8.5 Pfizer Recent Development

11.9 Huahai Pharmaceutical

11.9.1 Huahai Pharmaceutical Corporation Information

11.9.2 Huahai Pharmaceutical Description, Business Overview and Total Revenue

11.9.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered

11.9.5 Huahai Pharmaceutical Recent Development

11.10 Hisun Pharmaceutical

11.10.1 Hisun Pharmaceutical Corporation Information

11.10.2 Hisun Pharmaceutical Description, Business Overview and Total Revenue

11.10.3 Hisun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered

11.10.5 Hisun Pharmaceutical Recent Development

11.1 Teva

11.1.1 Teva Corporation Information

11.1.2 Teva Description, Business Overview and Total Revenue

11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered

11.1.5 Teva Recent Development

11.12 Zhejiang Medicine

11.12.1 Zhejiang Medicine Corporation Information

11.12.2 Zhejiang Medicine Description, Business Overview and Total Revenue

11.12.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)

11.12.4 Zhejiang Medicine Products Offered

11.12.5 Zhejiang Medicine Recent Development

11.13 Dr. Reddy’s Laboratories

11.13.1 Dr. Reddy’s Laboratories Corporation Information

11.13.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue

11.13.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)

11.13.4 Dr. Reddy’s Laboratories Products Offered

11.13.5 Dr. Reddy’s Laboratories Recent Development

11.14 Zhejiang NHU

11.14.1 Zhejiang NHU Corporation Information

11.14.2 Zhejiang NHU Description, Business Overview and Total Revenue

11.14.3 Zhejiang NHU Sales, Revenue and Gross Margin (2015-2020)

11.14.4 Zhejiang NHU Products Offered

11.14.5 Zhejiang NHU Recent Development

11.15 Bayer

11.15.1 Bayer Corporation Information

11.15.2 Bayer Description, Business Overview and Total Revenue

11.15.3 Bayer Sales, Revenue and Gross Margin (2015-2020)

11.15.4 Bayer Products Offered

11.15.5 Bayer Recent Development

11.16 NCPC

11.16.1 NCPC Corporation Information

11.16.2 NCPC Description, Business Overview and Total Revenue

11.16.3 NCPC Sales, Revenue and Gross Margin (2015-2020)

11.16.4 NCPC Products Offered

11.16.5 NCPC Recent Development

11.17 AbbVie

11.17.1 AbbVie Corporation Information

11.17.2 AbbVie Description, Business Overview and Total Revenue

11.17.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)

11.17.4 AbbVie Products Offered

11.17.5 AbbVie Recent Development

11.18 Shandong Xinhua Pharmaceutical

11.18.1 Shandong Xinhua Pharmaceutical Corporation Information

11.18.2 Shandong Xinhua Pharmaceutical Description, Business Overview and Total Revenue

11.18.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.18.4 Shandong Xinhua Pharmaceutical Products Offered

11.18.5 Shandong Xinhua Pharmaceutical Recent Development

11.19 Northeast Pharm

11.19.1 Northeast Pharm Corporation Information

11.19.2 Northeast Pharm Description, Business Overview and Total Revenue

11.19.3 Northeast Pharm Sales, Revenue and Gross Margin (2015-2020)

11.19.4 Northeast Pharm Products Offered

11.19.5 Northeast Pharm Recent Development

11.20 Harbin Pharmaceutical

11.20.1 Harbin Pharmaceutical Corporation Information

11.20.2 Harbin Pharmaceutical Description, Business Overview and Total Revenue

11.20.3 Harbin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.20.4 Harbin Pharmaceutical Products Offered

11.20.5 Harbin Pharmaceutical Recent Development

11.21 LKPC

11.21.1 LKPC Corporation Information

11.21.2 LKPC Description, Business Overview and Total Revenue

11.21.3 LKPC Sales, Revenue and Gross Margin (2015-2020)

11.21.4 LKPC Products Offered

11.21.5 LKPC Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

12.1 Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Region

12.1.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Regions 2021-2026

12.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions 2021-2026

12.2 North America Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)

12.2.1 North America: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)

12.2.2 North America: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)

12.2.3 North America: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)

12.3 Europe Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)

12.3.1 Europe: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)

12.3.2 Europe: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)

12.3.3 Europe: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)

12.4 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)

12.4.1 Asia Pacific: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)

12.4.2 Asia Pacific: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)

12.4.3 Asia Pacific: Active Pharmaceutical Ingredients (API) Market Size Forecast by Region (2021-2026)

12.5 Latin America Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)

12.5.1 Latin America: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)

12.5.2 Latin America: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)

12.5.3 Latin America: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)

12.6 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)

12.6.1 Middle East and Africa: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)

12.6.2 Middle East and Africa: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)

12.6.3 Middle East and Africa: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter’s Five Forces Analysis

13.5 Primary Interviews with Key Active Pharmaceutical Ingredients (API) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Active Pharmaceutical Ingredients (API) Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

List of Tables

Table 1. Active Pharmaceutical Ingredients (API) Market Segments

Table 2. Ranking of Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Synthetic APIs

Table 5. Major Manufacturers of Biotech APIs

Table 6. COVID-19 Impact Global Market: (Four Active Pharmaceutical Ingredients (API) Market Size Forecast Scenarios)

Table 7. Opportunities and Trends for Active Pharmaceutical Ingredients (API) Players in the COVID-19 Landscape

Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 9. Key Regions/Countries Measures against Covid-19 Impact

Table 10. Proposal for Active Pharmaceutical Ingredients (API) Players to Combat Covid-19 Impact

Table 11. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application 2020-2026 (K MT)

Table 12. Global Active Pharmaceutical Ingredients (API) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 13. Global Active Pharmaceutical Ingredients (API) Sales by Regions 2015-2020 (K MT)

Table 14. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Regions (2015-2020)

Table 15. Global Active Pharmaceutical Ingredients (API) Revenue by Regions 2015-2020 (US$ Million)

Table 16. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2015-2020) (K MT)

Table 17. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2015-2020)

Table 18. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 19. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)

Table 20. Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2015-2020) (US$ Million)

Table 21. Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)

Table 22. Key Manufacturers Active Pharmaceutical Ingredients (API) Price (2015-2020) (USD/MT)

Table 23. Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Active Pharmaceutical Ingredients (API) Product Type

Table 25. Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market

Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 27. Global Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)

Table 28. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2015-2020)

Table 29. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020) (US$ Million)

Table 30. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2015-2020)

Table 31. Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 32. Global Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)

Table 33. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2015-2020)

Table 34. North America Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)

Table 35. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)

Table 36. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)

Table 37. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)

Table 38. North America Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)

Table 39. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)

Table 40. North America Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)

Table 41. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)

Table 42. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)

Table 43. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)

Table 44. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)

Table 45. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)

Table 46. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)

Table 47. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)

Table 48. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)

Table 49. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)

Table 50. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2015-2020) (K MT)

Table 51. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2015-2020)

Table 52. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2015-2020) (US$ Million)

Table 53. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)

Table 54. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)

Table 55. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)

Table 56. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)

Table 57. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)

Table 58. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)

Table 59. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)

Table 60. Latin Americaa Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)

Table 61. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)

Table 62. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)

Table 63. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)

Table 64. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)

Table 65. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)

Table 66. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)

Table 67. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)

Table 68. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)

Table 69. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)

Table 71. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)

Table 72. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)

Table 73. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)

Table 74. Teva Corporation Information

Table 75. Teva Description and Major Businesses

Table 76. Teva Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 77. Teva Product

Table 78. Teva Recent Development

Table 79. Mylan Corporation Information

Table 80. Mylan Description and Major Businesses

Table 81. Mylan Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 82. Mylan Product

Table 83. Mylan Recent Development

Table 84. DSM Corporation Information

Table 85. DSM Description and Major Businesses

Table 86. DSM Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 87. DSM Product

Table 88. DSM Recent Development

Table 89. Aurobindo Pharma Corporation Information

Table 90. Aurobindo Pharma Description and Major Businesses

Table 91. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 92. Aurobindo Pharma Product

Table 93. Aurobindo Pharma Recent Development

Table 94. Aspen Corporation Information

Table 95. Aspen Description and Major Businesses

Table 96. Aspen Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 97. Aspen Product

Table 98. Aspen Recent Development

Table 99. Novartis Corporation Information

Table 100. Novartis Description and Major Businesses

Table 101. Novartis Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 102. Novartis Product

Table 103. Novartis Recent Development

Table 104. BASF Corporation Information

Table 105. BASF Description and Major Businesses

Table 106. BASF Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 107. BASF Product

Table 108. BASF Recent Development

Table 109. Pfizer Corporation Information

Table 110. Pfizer Description and Major Businesses

Table 111. Pfizer Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 112. Pfizer Product

Table 113. Pfizer Recent Development

Table 114. Huahai Pharmaceutical Corporation Information

Table 115. Huahai Pharmaceutical Description and Major Businesses

Table 116. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 117. Huahai Pharmaceutical Product

Table 118. Huahai Pharmaceutical Recent Development

Table 119. Hisun Pharmaceutical Corporation Information

Table 120. Hisun Pharmaceutical Description and Major Businesses

Table 121. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 122. Hisun Pharmaceutical Product

Table 123. Hisun Pharmaceutical Recent Development

Table 124. Sun Pharmaceutical Industries Corporation Information

Table 125. Sun Pharmaceutical Industries Description and Major Businesses

Table 126. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 127. Sun Pharmaceutical Industries Product

Table 128. Sun Pharmaceutical Industries Recent Development

Table 129. Zhejiang Medicine Corporation Information

Table 130. Zhejiang Medicine Description and Major Businesses

Table 131. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 132. Zhejiang Medicine Product

Table 133. Zhejiang Medicine Recent Development

Table 134. Dr. Reddy’s Laboratories Corporation Information

Table 135. Dr. Reddy’s Laboratories Description and Major Businesses

Table 136. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 137. Dr. Reddy’s Laboratories Product

Table 138. Dr. Reddy’s Laboratories Recent Development

Table 139. Zhejiang NHU Corporation Information

Table 140. Zhejiang NHU Description and Major Businesses

Table 141. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 142. Zhejiang NHU Product

Table 143. Zhejiang NHU Recent Development

Table 144. Bayer Corporation Information

Table 145. Bayer Description and Major Businesses

Table 146. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 147. Bayer Product

Table 148. Bayer Recent Development

Table 149. NCPC Corporation Information

Table 150. NCPC Description and Major Businesses

Table 151. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 152. NCPC Product

Table 153. NCPC Recent Development

Table 154. AbbVie Corporation Information

Table 155. AbbVie Description and Major Businesses

Table 156. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 157. AbbVie Product

Table 158. AbbVie Recent Development

Table 159. Shandong Xinhua Pharmaceutical Corporation Information

Table 160. Shandong Xinhua Pharmaceutical Description and Major Businesses

Table 161. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 162. Shandong Xinhua Pharmaceutical Product

Table 163. Shandong Xinhua Pharmaceutical Recent Development

Table 164. Northeast Pharm Corporation Information

Table 165. Northeast Pharm Description and Major Businesses

Table 166. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 167. Northeast Pharm Product

Table 168. Northeast Pharm Recent Development

Table 169. Harbin Pharmaceutical Corporation Information

Table 170. Harbin Pharmaceutical Description and Major Businesses

Table 171. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 172. Harbin Pharmaceutical Product

Table 173. Harbin Pharmaceutical Recent Development

Table 174. LKPC Corporation Information

Table 175. LKPC Description and Major Businesses

Table 176. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 177. LKPC Product

Table 178. LKPC Recent Development

Table 179. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Regions (2021-2026) (K MT)

Table 180. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Regions (2021-2026)

Table 181. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 182. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Regions (2021-2026)

Table 183. North America: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)

Table 184. North America: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)

Table 185. Europe: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)

Table 186. Europe: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)

Table 187. Asia Pacific: Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2021-2026) (K MT)

Table 188. Asia Pacific: Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2021-2026) (US$ Million)

Table 189. Latin America: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)

Table 190. Latin America: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)

Table 191. Middle East and Africa: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)

Table 192. Middle East and Africa: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)

Table 193. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 194. Key Challenges

Table 195. Market Risks

Table 196. Main Points Interviewed from Key Active Pharmaceutical Ingredients (API) Players

Table 197. Active Pharmaceutical Ingredients (API) Customers List

Table 198. Active Pharmaceutical Ingredients (API) Distributors List

Table 199. Research Programs/Design for This Report

Table 200. Key Data Information from Secondary Sources

Table 201. Key Data Information from Primary Sources

List of Figures

Figure 1. Active Pharmaceutical Ingredients (API) Product Picture

Figure 2. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020 & 2026

Figure 3. Synthetic APIs Product Picture

Figure 4. Biotech APIs Product Picture

Figure 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020 & 2026

Figure 6. CNS

Figure 7. Cardiovascular

Figure 8. Genitourinary/Hormonal Drugs

Figure 9. Respiratory

Figure 10. Rheumatology

Figure 11. Diabetes

Figure 12. Oncology

Figure 13. Others

Figure 14. Active Pharmaceutical Ingredients (API) Report Years Considered

Figure 15. Global Active Pharmaceutical Ingredients (API) Market Size 2015-2026 (US$ Million)

Figure 16. Global Active Pharmaceutical Ingredients (API) Sales 2015-2026 (K MT)

Figure 17. Global Active Pharmaceutical Ingredients (API) Market Size Market Share by Region: 2020 Versus 2026

Figure 18. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2015-2020)

Figure 19. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region in 2019

Figure 20. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)

Figure 21. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2019

Figure 22. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturer in 2019

Figure 23. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2019

Figure 24. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 25. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)

Figure 26. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2019

Figure 27. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2015-2020)

Figure 28. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2019

Figure 29. Global Active Pharmaceutical Ingredients (API) Market Share by Price Range (2015-2020)

Figure 30. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)

Figure 31. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2019

Figure 32. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2015-2020)

Figure 33. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application in 2019

Figure 34. North America Active Pharmaceutical Ingredients (API) Sales Growth Rate 2015-2020 (K MT)

Figure 35. North America Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2015-2020 (US$ Million)

Figure 36. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2019

Figure 37. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2019

Figure 38. U.S. Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 39. U.S. Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 40. Canada Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 41. Canada Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 42. North America Active Pharmaceutical Ingredients (API) Market Share by Type in 2019

Figure 43. North America Active Pharmaceutical Ingredients (API) Market Share by Application in 2019

Figure 44. Europe Active Pharmaceutical Ingredients (API) Sales Growth Rate 2015-2020 (K MT)

Figure 45. Europe Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2015-2020 (US$ Million)

Figure 46. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2019

Figure 47. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2019

Figure 48. Germany Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 49. Germany Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. France Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 51. France Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. U.K. Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 53. U.K. Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Italy Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 55. Italy Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Russia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 57. Russia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Europe Active Pharmaceutical Ingredients (API) Market Share by Type in 2019

Figure 59. Europe Active Pharmaceutical Ingredients (API) Market Share by Application in 2019

Figure 60. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Growth Rate 2015-2020 (K MT)

Figure 61. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2015-2020 (US$ Million)

Figure 62. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region in 2019

Figure 63. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2019

Figure 64. China Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 65. China Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Japan Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 67. Japan Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. South Korea Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 69. South Korea Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. India Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 71. India Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Australia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 73. Australia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Taiwan Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 75. Taiwan Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Indonesia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 77. Indonesia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Thailand Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 79. Thailand Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Malaysia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 81. Malaysia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Philippines Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 83. Philippines Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Vietnam Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 85. Vietnam Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Asia Pacific Active Pharmaceutical Ingredients (API) Market Share by Type in 2019

Figure 87. Asia Pacific Active Pharmaceutical Ingredients (API) Market Share by Application in 2019

Figure 88. Latin America Active Pharmaceutical Ingredients (API) Sales Growth Rate 2015-2020 (K MT)

Figure 89. Latin America Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2015-2020 (US$ Million)

Figure 90. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2019

Figure 91. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2019

Figure 92. Mexico Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 93. Mexico Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Brazil Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 95. Brazil Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Argentina Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 97. Argentina Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 98. Latin America Active Pharmaceutical Ingredients (API) Market Share by Type in 2019

Figure 99. Latin America Active Pharmaceutical Ingredients (API) Market Share by Application in 2019

Figure 100. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Growth Rate 2015-2020 (K MT)

Figure 101. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2015-2020 (US$ Million)

Figure 102. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2019

Figure 103. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2019

Figure 104. Turkey Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 105. Turkey Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Saudi Arabia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 107. Saudi Arabia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 108. UAE Active Pharmaceutical Ingredients (API) Sales Growth Rate (2015-2020) (K MT)

Figure 109. UAE Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2015-2020) (US$ Million)

Figure 110. Middle East and Africa Active Pharmaceutical Ingredients (API) Market Share by Type in 2019

Figure 111. Middle East and Africa Active Pharmaceutical Ingredients (API) Market Share by Application in 2019

Figure 112. Teva Total Revenue (US$ Million): 2019 Compared with 2018

Figure 113. Mylan Total Revenue (US$ Million): 2019 Compared with 2018

Figure 114. DSM Total Revenue (US$ Million): 2019 Compared with 2018

Figure 115. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 116. Aspen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 117. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 118. BASF Total Revenue (US$ Million): 2019 Compared with 2018

Figure 119. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 120. Huahai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 121. Hisun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 122. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018

Figure 123. Zhejiang Medicine Total Revenue (US$ Million): 2019 Compared with 2018

Figure 124. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 125. Zhejiang NHU Total Revenue (US$ Million): 2019 Compared with 2018

Figure 126. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 127. NCPC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 128. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018

Figure 129. Shandong Xinhua Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 130. Northeast Pharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 131. Harbin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 132. LKPC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 133. North America Active Pharmaceutical Ingredients (API) Sales Growth Rate Forecast (2021-2026) (K MT)

Figure 134. North America Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 135. Europe Active Pharmaceutical Ingredients (API) Sales Growth Rate Forecast (2021-2026) (K MT)

Figure 136. Europe Active Pharmaceutical Ingredients (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 137. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Growth Rate Forecast (2021-2026) (K MT)

Figure 138. Asia Pacifi

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Active Pharmaceutical Ingredients (API) Market Outlook 2022

Published Date: April 2020

Report Code: QYRE-Auto-31E2189

Global Active Pharmaceutical Ingredients (API) Market Outlook 2022

FEATURED COMPANIES

Active Pharmaceutical Ingredients Market

Trends Infuencing the Global API Market

Active Pharmaceutical Ingredients Market Share

Segment by Type

Segment by Application

Segment by Company

Production by Region

Consumption by Region

Scope of API Market Report

Frequently Asked Questions About This Report

1. How big is the Active Pharmaceutical Ingredients Market?

2. Who are the Top manufacturers in the API Industry?

3. Does the report provides covid-19 impact analysis?

4. Which region holds largest market share in the Active Pharmaceutical Ingredients?

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36S14110

Thu May 02 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-14G14630

Thu May 02 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-7R14828

Thu May 02 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38S14317

Thu May 02 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions